- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
43 Ruxolitinib Trials Near You
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerSelinexor + Ruxolitinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
350 Participants Needed
Trial Details
Key Eligibility Criteria
572 Participants Needed
Ruxolitinib for Large Granular Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
28 Participants Needed
Ruxolitinib + CPX-351 for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
12 Participants Needed
Trial Details
Key Eligibility Criteria
64 Participants Needed
Axatilimab + Ruxolitinib for Graft-versus-Host Disease
Trial Details
Key Eligibility Criteria
120 Participants Needed
Parsaclisib Combinations for B-Cell Cancers
Trial Details
Key Eligibility Criteria
112 Participants Needed
Ruxolitinib + Chemotherapy for Leukemia
Trial Details
Key Eligibility Criteria
171 Participants Needed
Ruxolitinib for Acute Graft-versus-Host Disease
Trial Details
Key Eligibility Criteria
98 Participants Needed
INCB057643 +/- Ruxolitinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
231 Participants Needed
Ruxolitinib Cream for Prurigo Nodularis
Trial Details
Key Eligibility Criteria
190 Participants Needed
Ruxolitinib Cream for Prurigo
Trial Details
Key Eligibility Criteria
204 Participants Needed
Ruxolitinib for Lung Dysfunction Post Stem Cell Transplant
Trial Details
Key Eligibility Criteria
40 Participants Needed
TL-895 + Ruxolitinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
70 Participants Needed
Ruxolitinib for Chronic Graft-versus-Host Disease
Trial Details
Key Eligibility Criteria
30 Participants Needed
Navtemadlin + Ruxolitinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
85 Participants Needed
Navitoclax + Ruxolitinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
330 Participants Needed
Ruxolitinib for Chronic Myelomonocytic Leukemia
Trial Details
Key Eligibility Criteria
29 Participants Needed
Ruxolitinib + Ulixertinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
37 Participants Needed
Why Other Patients Applied
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
Ruxolitinib + Temozolomide + Radiation for Glioblastoma
Trial Details
Key Eligibility Criteria
60 Participants Needed
Total Therapy XVII for Leukemia
Trial Details
Key Eligibility Criteria
790 Participants Needed
Ruxolitinib Cream for Vitiligo
Trial Details
Key Eligibility Criteria
180 Participants Needed
Ruxolitinib + Enzalutamide for Prostate Cancer
Trial Details
Key Eligibility Criteria
39 Participants Needed
BMS-986158 + Ruxolitinib/Fedratinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
216 Participants Needed
Ruxolitinib Cream for Prurigo
Trial Details
Key Eligibility Criteria
23 Participants Needed
Ruxolitinib for Precancerous Breast Conditions
Trial Details
Key Eligibility Criteria
100 Participants Needed
Ruxolitinib Cream for Eczema
Trial Details
Key Eligibility Criteria
241 Participants Needed
Ruxolitinib Continuation for Cancer
Trial Details
Key Eligibility Criteria
10 Participants Needed
INCB000928 + Ruxolitinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
84 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.